Company specializing in collecting and preserving menstrual stem cells that can be used in present and future regenenerative and cosmetic therapies in the USA.
Commercializing cell-based therapies for oncology, injury, degenerative and multiple chronic diseases disease, is its human embryonic platform. Subsidiary in Edinburgh, Scotland, mainly based in Menlo Park, California.
Researches, develops, and markets cell-based therapies. Includes, with details of clinical trials information for investors, and profile of company in Palo Alto, California.
Develops and sells kits and reagents for selection, media for enrichment, as well as offering contract assays, proficiency testing and training. Includes international laboratories, headquartered from Vancouver, Canada.
Developing therapies for the treatment of bone defects and myocardial regeneration, utilizing somatic stem cells isolated from cord blood. Based in Cambridge, Massachusetts.
Company conducts research using autologous human cells in a serum free medium to treat incurable diseases. The results propose possible new treatments for regeneration of diseased tissues. Based in Geneva, Switzerland.
Specializing initially in hematopoietic stem cells and developing expansion from umbilical cord blood using its proprietary bioreactor and 3-D technology platform. Includes investor data and overview of company in Haifa, Israel.
Research and development of retrodifferentiation technology, used to create stem cells from mature adult cells. Includes technological and corporate overview, with FAQ and contacts in London, UK.
Antibodies, markers, reagents and recent reviews of their applications, links to conferences. Online catalog and purchase available from Cambridge, England and Massachusetts.
Offers isolation and concentration from a sample of fat for treatment of injuries to tendons, ligaments, and fractures in performance horses. Includes explanation, case studies, news, description of services for horse owners and veterinarians, with contacts in Poway, California.
Biotech company in the field of cell therapies including skin and hair regeneration products. Currently in clinical phase 3 trials in the USA, Canada and UK, headquartered in Cambridge, England.
Inventors of ethical umbilical cord mesenchymal and epithelial progenitor cell lines targeted at regenerative medicine. Also offering primary skin cell culture systems, both normal and diseased, and customised research in Singapore.
Plasticell is a privately held biotechnology company using novel stem cell culture and drug discovery platforms to produce regenerative small molecule drugs.
Offers isolation, validation, differentiation, electroporation and mouse chimera production, using standard embryonic murine strains, transgenic or knockout models. Contact in USA.
Biopharmaceutical company developing adult stem cell products for current pre-clinical and future clinical studies in the United States and for on-going pre-clinical and clinical studies internationally.
Center for reproductive medicine and stem cell therapy in India. Provides a clinic profile and information on the therapeutic services available for various disorders.
Clinic based in Guatemala, Central America, offering stem cell transplantation. Explains the treatments offered and provides information for local and foreign patients and financing arrangements.
Developing proprietary, cell-based therapies from adult adipose tissue, targeting cardiovascular disease, orthopedic conditions, gastrointestinal disorders and autologous reconstructive surgery. International contacts with headquarters in San Diego, California.
Commercialization of cellular therapies, with cGMP-compliant manufacturing and consulting in validation, processing, storage and transportation. Facilities in Hackensack, New Jersey and Mountain View, California.